Literature DB >> 7527589

Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO.

J M Ding1, D Chen, E T Weber, L E Faiman, M A Rea, M U Gillette.   

Abstract

Circadian rhythms of mammals are timed by an endogenous clock with a period of about 24 hours located in the suprachiasmatic nucleus (SCN) of the hypothalamus. Light synchronizes this clock to the external environment by daily adjustments in the phase of the circadian oscillation. The mechanism has been thought to involve the release of excitatory amino acids from retinal afferents to the SCN. Brief treatment of rat SCN in vitro with glutamate (Glu), N-methyl-D-aspartate (NMDA), or nitric oxide (NO) generators produced lightlike phase shifts of circadian rhythms. The SCN exhibited calcium-dependent nitric oxide synthase (NOS) activity. Antagonists of NMDA or NOS pathways blocked Glu effects in vitro, and intracerebroventricular injection of a NOS inhibitor in vivo blocked the light-induced resetting of behavioral rhythms. Together, these data indicate that Glu release, NMDA receptor activation, NOS stimulation, and NO production link light activation of the retina to cellular changes within the SCN mediating the phase resetting of the biological clock.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527589     DOI: 10.1126/science.7527589

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  135 in total

1.  Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo.

Authors:  E M Mintz; C L Marvel; C F Gillespie; K M Price; H E Albers
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Enhanced NMDA receptor activity in retinal inputs to the rat suprachiasmatic nucleus during the subjective night.

Authors:  C M Pennartz; R Hamstra; A M Geurtsen
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

3.  Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons.

Authors:  C N Allen; Z G Jiang; K Teshima; T Darland; M Ikeda; C S Nelson; D I Quigley; T Yoshioka; R G Allen; M A Rea; D K Grandy
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

4.  A rapid and transient synthesis of nitric oxide (NO) by a constitutively expressed type II NO synthase in the guinea-pig suprachiasmatic nucleus.

Authors:  S J Starkey; A L Grant; R M Hagan
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

5.  Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators.

Authors:  N Le Minh; F Damiola; F Tronche; G Schütz; U Schibler
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

6.  Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor.

Authors:  J Hannibal; F Jamen; H S Nielsen; L Journot; P Brabet; J Fahrenkrug
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

7.  Circadian and photic regulation of phosphorylation of ERK1/2 and Elk-1 in the suprachiasmatic nuclei of the Syrian hamster.

Authors:  Andrew N Coogan; Hugh D Piggins
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

8.  Differential cAMP gating of glutamatergic signaling regulates long-term state changes in the suprachiasmatic circadian clock.

Authors:  S A Tischkau; E A Gallman; G F Buchanan; M U Gillette
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

9.  Light and glutamate-induced degradation of the circadian oscillating protein BMAL1 during the mammalian clock resetting.

Authors:  T Tamaru; Y Isojima; T Yamada; M Okada; K Nagai; K Takamatsu
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

10.  Excitatory mechanisms in the suprachiasmatic nucleus: the role of AMPA/KA glutamate receptors.

Authors:  Stephan Michel; Jason Itri; Christopher S Colwell
Journal:  J Neurophysiol       Date:  2002-08       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.